New drug PEEL-224 enters first human tests for advanced cancers
Disease control
Recruiting now
This early-phase study is testing a new drug called PEEL-224 in 65 people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug can shrink tu…
Phase: PHASE1 • Sponsor: Peel Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC